Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure

Digestive Diseases and Sciences

Volumn 57, Issue 3, 2012, Pages 667-674

  Wang, Li Yuan ^a   Meng, Qing Hua ^b   Zou, Zhi Qiang ^c   Fan, Yu Chen ^a,d   Han, Jie ^a   Qi, Zhao Xia ^a   Ge, Jian ^d   Xu, Ailing ^c   Wang, Si Kui ^e   Wang, Kai ^a,d  

^a SHANDONG UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Yantai Infectious Disease Hospital   (China)

^d SHANDONG UNIVERSITY   (China)

^e LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Acute on chronic hepatitis B liver failure; Interleukin 17; Model for end stage liver disease; T helper 17 cells

Indexed keywords

BILIRUBIN; INTERLEUKIN 17; MESSENGER RNA; PROTHROMBIN; BIOLOGICAL MARKER; IL17A PROTEIN, HUMAN;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SURVIVOR; TH17 CELL; ACUTE LIVER FAILURE; BLOOD; GENE EXPRESSION; GENETICS; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; BIOLOGICAL MARKERS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-17; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TH17 CELLS; YOUNG ADULT;

EID: 84859516033     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1930-5     Document Type: Article

References (38)

1. Lok AS. The maze of treatments for hepatitis B. N Engl J Med. 2005;352:2743-2746. (Pubitemid 41007830)
2. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3: 269-282.
3. Liu CL, Fan ST, Lo CM, et al. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation. 2003;76:1174-1179.
4. Apostolidis SA, Crispin JC, Tsokos GC. IL-17-producing T cells in lupus nephritis. Lupus. 2011;20:120-124.
5. Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol. 2007;19: 362-371. (Pubitemid 351274046)
6. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-producing gamma delta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009;31:321-330.
7. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4? effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132. (Pubitemid 41541790)
8. Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(?) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51:81-91.
9. Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010;25:750-757.
10. Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol. 2010;30:60-67.
11. Yasumi Y, Takikawa Y, Endo R, Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res. 2007;37:248-254. (Pubitemid 46505838)
12. Ye Y, Xie X, Yu J, et al. Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol. 2010; 30:546-555.
13. Anderson SJ, Coleclough C. Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the cell surface by two mechanisms. J Immunol. 1993;151:5123-5134. (Pubitemid 23332322)
14. Picker LJ, Singh MK, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 1995;86:1408-1419.
15. Chang YH, Yu CW, Lai LC, et al. Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer. Cancer. 2010;116:4800-4809.
16. Bambha K, Kim WR, Kremers WK, et al. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant. 2004;4:1798-1804. (Pubitemid 39434440)
17. Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol. 2008;38:2636-2649.
18. Crispin JC, Oukka M, Bayliss G, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181:8761-8766.
19. Glader P, Smith ME, Malmhall C, et al. Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin. Eur Respir J. 2010;36:1155-1164.
20. Pitcher C, Honing S, Fingerhut A, Bowers K, Marsh M. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation. Mol Biol Cell. 1999;10:677-691. (Pubitemid 29144631)
21. Figueroa-Vega N, Alfonso-Perez M, Benedicto I, Sanchez-Madrid F, Gonzalez-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2010;95: 953-962.
22. Yang J, Chu Y, Yang X, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 2009;60:1472-1483.
23. Zhang Z, Zou ZS, Fu JL, et al. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol. 2008;49:396-406.
24. Zou Y, Chen T, Han M, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466-475.
25. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4 ? CD25 ? regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006;177:739-747. (Pubitemid 43939189)
26. Hu X, Ma S, Huang X, et al. Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease. J Viral Hepat. 2011;18:458-467.
27. Leifeld L, Cheng S, Ramakers J, et al. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology. 2002;36:1001-1008.
28. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26:912-919. (Pubitemid 44323408)
29. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis. 2007;27:339-350. (Pubitemid 350071835)
30. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature. 2008;453:1051-1057. (Pubitemid 351871737)
31. Wang Q, Zheng Y, Huang Z, et al. Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol. 2011;12:25.
32. Hartel C, Bein G, Muller-Steinhardt M, Kluter H. Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods. 2001;249:63-71. (Pubitemid 32171959)
33. Li J, Wu W, Peng G, et al. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol. 2010;88:834-841.
34. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40:897-903. (Pubitemid 38670122)
35. Sun QF, Ding JG, Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat. 2009;16:464-470.
36. Zheng MH, Shi KQ, Fan YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol. 2011;9:351-356, e353.
37. Stauber RE, Wagner D, Stadlbauer V, et al. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver Int. 2009;29:1516-1520.
38. Tanaka JS. "How big Is big enough?": sample size and goodness of fit in structural equation models with latent variables. Child Dev. 1987;58:134-146.